Tony Jourdan

9PUBLICATIONS
15CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular medicineNutrigenomics and personalised nutritionBiologically active moleculesCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 11, 2025
Leveraging Peripheral CB1 Antagonism in 1,4,5,6-Tetrahydropyridazine-Based Amidine Substituted Sulfonyl Analogs for Treating Metabolic Disorders.

Pinaki Bhattacharjee, Szabolcs Dvorácskó, Paul Volesky

|Jul 12, 2025
Blockade of cannabinoid CB<sub>1</sub> receptors potentiates the anti-fibrotic effects mediated by SGLT2 inhibition in a mouse model of diabetic nephropathy.

Océane Pointeau, Awa Isma Ba, Audrey Geissler

|Mar 27, 2025
A Simplified and Robust Model for the Study of Diabetic Nephropathy: Streptozotocin-Induced Diabetic Mice Fed a High-Protein Diet.

Océane Pointeau, Romain Barbosa, Maéva Loriot

|Mar 25, 2022
Chemical Synthesis, Pharmacokinetic Properties and Biological Effects of JM-00266, a Putative Non-Brain Penetrant Cannabinoid Receptor 1 Inverse Agonist.

Tania Muller, Laurent Demizieux, Stéphanie Troy-Fioramonti

|Jul 29, 2021
CB<sub>1</sub> R and iNOS are distinct players promoting pulmonary fibrosis in Hermansky-Pudlak syndrome.

Resat Cinar, Joshua K Park, Charles N Zawatsky

|Jul 19, 2020
Simultaneous Inhibition of Peripheral CB1R and iNOS Mitigates Obesity-Related Dyslipidemia Through Distinct Mechanisms.

Célia Roger, Chloé Buch, Tania Muller

Pageof 2

Frequent Collaborators

4 joint publications

Resat Cinar

2 joint publications

Julia Leemput

2 joint publications

Sébastien Zwe Causse

2 joint publications

Bruno Vergès